Genomines
Paris, France · $45.0M raised
- Headquarters
- Paris
- Business Model
- B2B
- Website
- genomines.com
- Total Funding
- $45.0M
- Last Round
- Series ASep 2025
- Rounds
- 1
About
Biotech startup using plants to extract battery-grade nickel as a clean alternative to traditional mining.
Summary
Genomines is a Biotech company based in Paris, France. It has raised $45.0M in total across 1 round, most recently a Series A round in Sep 2025. Investors include Engine Ventures, Forbion Capital Partners and Lowercarbon Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Investors
Similar Companies
Decarbonizing the chemicals industry.
Pioneering sustainable urban community and innovation hub in Abu Dhabi.
Self-driving cars.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...